303 related articles for article (PubMed ID: 31237374)
1. Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients.
Fang CY; Lin YH; Chen CL
J Oral Pathol Med; 2019 Sep; 48(8):712-719. PubMed ID: 31237374
[TBL] [Abstract][Full Text] [Related]
2. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.
Ko HH; Cheng SL; Lee JJ; Chen HM; Kuo MY; Cheng SJ
Head Neck; 2017 Jul; 39(7):1327-1332. PubMed ID: 28301069
[TBL] [Abstract][Full Text] [Related]
3. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
Ko HH; Peng HH; Cheng SJ; Kuo MY
Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
[TBL] [Abstract][Full Text] [Related]
4. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
[TBL] [Abstract][Full Text] [Related]
5. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.
Byatnal AA; Byatnal A; Sen S; Guddattu V; Solomon MC
Pathol Oncol Res; 2015 Sep; 21(4):1123-31. PubMed ID: 25962348
[TBL] [Abstract][Full Text] [Related]
7. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis.
Liu R; Zheng S; Yang CY; Yu Y; Peng S; Ge Q; Lin Q; Li Q; Shi W; Shao Y
Medicine (Baltimore); 2021 Apr; 100(14):e25454. PubMed ID: 33832153
[TBL] [Abstract][Full Text] [Related]
9. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
[TBL] [Abstract][Full Text] [Related]
10. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
[TBL] [Abstract][Full Text] [Related]
11. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
12. The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma.
Liu J; Ban H; Liu Y; Ni J
Sci Rep; 2021 Sep; 11(1):18228. PubMed ID: 34521883
[TBL] [Abstract][Full Text] [Related]
13. CCL18 overexpression predicts a worse prognosis in oral squamous cell carcinoma (OSCC).
Mao L; Zhuang R; Qin L; Han Z; Huang X; Chen R; Su Y; Ge L; Yang J; Li J; Wang X
Neoplasma; 2020 May; 67(3):700-706. PubMed ID: 32202908
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
15. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
[TBL] [Abstract][Full Text] [Related]
17. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
18. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma.
Xie C; Ye X; Zeng L; Zeng X; Cao D
J Gastroenterol; 2023 Oct; 58(10):1030-1042. PubMed ID: 37500927
[TBL] [Abstract][Full Text] [Related]
19. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
20. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]